The Neuro-Data Economy: Strategic Frameworks for Consumer Trust and Privacy in the Commercialization of Neural Implants

The emerging neurotechnology industry, led by firms like Neuralink, is rapidly transitioning from purely medical applications to the broader consumer market of human enhancement. This pivot introduces unprecedented ethical and business risks, particularly concerning the commercialization of neural data and the long-term sustainability of implanted devices. This paper investigates these challenges to develop a strategic framework for building consumer trust and ensuring corporate viability. This study employs a multi-faceted approach, combining a case study analysis of the corporate failure of Second Sight Medical Products with a comparative review of the business strategies of key neurotech players in 2026 (Neuralink, Synchron, Paradromics, Blackrock Neurotech). It further analyzes the nascent regulatory landscape for neural data privacy, including the General Data Protection Regulation (GDPR) and emerging U.S. state-level “neurorights” legislation. The analysis reveals a critical gap in current business models and regulatory frameworks. The Second Sight case, where patients were left with unsupported, “bricked” retinal implants, serves as a stark warning against prioritizing short-term innovation over long-term corporate responsibility. Traditional one-time sale models are inadequate for permanent implants, while pure subscription models introduce profound ethical hazards. The commercialization of neural data, the most intimate of all personal information, represents a pivotal source of both value and systemic risk. This paper proposes a novel strategic framework for sustainable business models in the neurotech sector. It moves beyond conventional models to advocate for hybrid structures, such as tiered service agreements, industry-backed legacy support consortia, and escrow-based continuity funds. The framework is designed to help firms navigate the neuro-data economy by aligning profitability with the ethical imperatives of long-term patient support and robust data privacy, thereby building the consumer trust essential for market acceptance.